SCHEDULE: Bard Associates Reports Stake in Modular Medical

Bard Associates, Inc. has disclosed a beneficial ownership of 102,831 shares, representing 0.1% of the outstanding common stock of Modular Medical, Inc.

Summary

• Bard Associates, Inc. has filed a Schedule 13G, indicating a change in its beneficial ownership of Modular Medical, Inc. common stock.
• The filing reports that Bard Associates, Inc. beneficially owns 102,831 shares of Modular Medical, Inc. common stock.
• This ownership represents approximately 0.1% of the total class of securities.
• Bard Associates, Inc. has sole voting power over 3,716 shares and sole dispositive power over 3,716 shares.
• The company has shared dispositive power over 99,115 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of beneficial ownership without significant new financial or strategic information.

Positives

• Bard Associates, Inc. has a disclosed beneficial ownership in Modular Medical, Inc., indicating investment interest.
• The ownership stake is held in the ordinary course of business and not for the purpose of influencing control.

Future Outlook

No specific future outlook or guidance is provided in this filing, as it pertains to beneficial ownership disclosure.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11."
• "After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct."

Industry Context

StockSavvy.ai notes that Schedule 13G filings are standard disclosures for institutional investors and significant shareholders, indicating passive investment rather than control-seeking behavior. This filing by Bard Associates, Inc. provides transparency regarding its stake in Modular Medical, Inc.

Stakeholder Impact

• Shareholders: Provides transparency on a significant institutional investor's stake, which may be of interest for understanding ownership composition.

Key Dates

Keywords

Schedule 13G, Beneficial Ownership, Modular Medical, Inc., Bard Associates, Inc., Common Stock, SEC Filing, Investment